FilingSEC EDGAR8-K/A
Processa Pharmaceuticals Files Amendment to Update Financial Information Regarding Vidya Acquisition
· SEC accepted
StageAcquisition Completed
Filing content
The company filed an amendment to its 8-K to include audited financial statements of the acquired entity, Vidya Therapeutics, and pro forma financial information.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…